Members of the European Parliament (MEPs) today urged the Commission to address the increase in HIV/AIDS, tuberculosis and viral hepatitis cases in the EU and to develop long-term programs.
A harmonized infection surveillance programs needed to immediately detect outbreaks of these contagious diseases, assess trends in prevalence, provide disease burden estimates and effectively track in real time how diagnosis, treatment and care are managed. As HIV remains the communicable disease bearing the greatest social stigma, the Commission and member states should facilitate access to innovative treatments, also for the most vulnerable groups, and combat social stigma.
They encourage member states to make HIV tests available free of charge, to ensure early detection.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze